A detailed history of Man Group PLC transactions in Alkermes Plc. stock. As of the latest transaction made, Man Group PLC holds 873,633 shares of ALKS stock, worth $20.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
873,633
Previous 926,189 5.67%
Holding current value
$20.4 Million
Previous $25.7 Million 7.95%
% of portfolio
0.06%
Previous 0.07%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$26.4 - $32.56 $1.39 Million - $1.71 Million
-52,556 Reduced 5.67%
873,633 $23.6 Million
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $9.31 Million - $11.4 Million
398,391 Added 75.48%
926,189 $25.7 Million
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $13.8 Million - $16.2 Million
507,569 Added 2509.12%
527,798 $14.8 Million
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $560,650 - $665,302
-19,783 Reduced 49.44%
20,229 $633,000
Q1 2023

May 15, 2023

SELL
$25.31 - $29.02 $6.67 Million - $7.65 Million
-263,639 Reduced 86.82%
40,012 $1.13 Million
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $2.44 Million - $2.92 Million
111,243 Added 57.82%
303,651 $7.93 Million
Q3 2022

Nov 14, 2022

SELL
$22.0 - $31.87 $1.92 Million - $2.78 Million
-87,317 Reduced 31.22%
192,408 $4.3 Million
Q2 2022

Aug 15, 2022

BUY
$26.4 - $30.54 $5.02 Million - $5.81 Million
190,165 Added 212.33%
279,725 $8.33 Million
Q1 2022

May 16, 2022

BUY
$23.07 - $27.99 $206,015 - $249,950
8,930 Added 11.08%
89,560 $2.36 Million
Q4 2021

Feb 14, 2022

SELL
$21.47 - $32.08 $303,650 - $453,707
-14,143 Reduced 14.92%
80,630 $1.88 Million
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $945,339 - $1.3 Million
40,451 Added 74.47%
94,773 $2.92 Million
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $4.26 Million - $5.71 Million
-226,897 Reduced 80.68%
54,322 $1.33 Million
Q1 2021

May 17, 2021

SELL
$18.21 - $23.2 $265,647 - $338,441
-14,588 Reduced 4.93%
281,219 $5.25 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $965,891 - $1.39 Million
-62,761 Reduced 17.5%
295,807 $5.9 Million
Q3 2020

Nov 16, 2020

BUY
$16.16 - $20.66 $4.58 Million - $5.86 Million
283,419 Added 377.14%
358,568 $5.94 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $19.41 $640,437 - $933,950
-48,117 Reduced 39.04%
75,149 $1.46 Million
Q1 2020

May 15, 2020

SELL
$13.06 - $21.24 $1.78 Million - $2.9 Million
-136,379 Reduced 52.53%
123,266 $1.78 Million
Q4 2019

Feb 18, 2020

BUY
$17.29 - $21.74 $2.42 Million - $3.04 Million
140,064 Added 117.13%
259,645 $5.3 Million
Q3 2019

Nov 14, 2019

BUY
$19.51 - $24.28 $160,664 - $199,945
8,235 Added 7.4%
119,581 $2.33 Million
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $2.25 Million - $3.91 Million
104,755 Added 1589.36%
111,346 $2.51 Million
Q1 2019

May 15, 2019

SELL
$28.4 - $36.49 $33,682 - $43,277
-1,186 Reduced 15.25%
6,591 $240,000
Q4 2018

Feb 14, 2019

SELL
$27.94 - $44.61 $2.05 Million - $3.28 Million
-73,500 Reduced 90.43%
7,777 $229,000
Q3 2018

Nov 14, 2018

BUY
$38.6 - $46.12 $2.3 Million - $2.74 Million
59,491 Added 273.07%
81,277 $3.45 Million
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $573,356 - $726,024
14,136 Added 184.78%
21,786 $897,000
Q1 2018

May 15, 2018

BUY
$53.61 - $67.26 $410,116 - $514,539
7,650 New
7,650 $443,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $3.84B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.